Investigation of in Vivo Endogenous and/or Exogenous Production of Phenolic Metabolites Using (un)Targeted Metabolomics
NCT ID: NCT06028659
Last Updated: 2025-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2023-10-25
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
For the proposed study, 30 healthy adults will be recruited and, if considered able to participate, will follow a standardized diet that is restricted in (poly)phenol intake and will be randomly divided into two groups: one will receive a known source of (poly)phenols (coffee) and the other will receive water, keeping the restriction of (poly)phenol from the diet. The duration of one phase is 4 days + 12 hours, during which urine, feces, and saliva will be collected. Then, after a 2-week-interval, subjects will repeat the experiment, except that this time the group who had coffee will have water, and vice versa. Again, urine and feces will be collected. The objective of the study is to identify and quantify LMWP mainly in urine, but also in feces, and try to understand how much was produced when there was no (poly)phenols in the diet compared with when there was ingestion of coffee (poly)phenols. The production of LMWP without coffee could be because of their production from other sources, like the metabolism of amino acids, proteins, and catecholamines (i.e. dopamine). The composition of the gut microbiota and relevant genetic information can alter the metabolism of (poly)phenols and will be considered in the analyses. Knowing how much of LMWP actually comes from the diet is important to understand the relevance and health benefits of these molecules.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Coffee Polyphenols Antioxidants
NCT01832662
Investigation of Acute Mood and Cognitive Performance Effects of Beverages Containing Phenolics in Healthy Adults
NCT02675621
Effects of Flavanoids in Essential Hypertension, Type 2 Diabetes and Healthy Persons
NCT03722199
Polyphenols and Insulin Resistance
NCT01478841
The Effects of a Polyphenol-enriched Fruit Drink on Metabolic Health
NCT01706653
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Volunteers freely accepting to participate to the study will be asked for their written informed consent. Information to the volunteers will be provided before and separately from the consent form. These information sheets and the informed consent forms have been prepared according to the Oviedo Convention and consider the guide of the local Ethics Committee. After obtaining their written informed consent, volunteers will undergo a screening visit to determine eligibility and collect personal data.
Privacy of the volunteers will be assured through pseudoanonymization by the attribution of a personal alphanumeric code. Recruited volunteers will also sign an authorisation to the use of personal information and retrieved data.
After recruitment, subjects will attend a first visit, when personal data will be collected, and body composition and anthropometry parameters measured. Then, they will receive the foods, supplements, and materials necessary to follow the study. The recruited subjects will be requested to follow a low-(poly)phenol diet, which will be the same for all the volunteers and maintained for the whole period of the intervention study. The foods, preparation mode, and times for eating the meals will be provided by the sponsor. The diet will be personalised to approximate the necessary calories based on the measured basal metabolic rate, multiplied by the physical activity level set at 1.45, and there will be quantitative variations on the low-(poly)phenol diet based on the daily energy requirement: 1500 kcal/day, 1750 kcal/day, 2000 kcal/day, 2250 kcal/day, 2500 kcal/day, 2750 kcal/day, or 3000 kcal/day, all with nutritionally balanced amounts of protein, fat, and carbohydrates. In addition, participants will be requested to restrict physical exercise during the study duration.
Subjects will be asked to collect urine produced during the 60h prior the intervention, starting from the evening prior the first day of diet (from 21.00 of the night prior the first day of diet) and every 12 hours (60-48h, 48-36h, 36-24h, 24-12h, 12-0h), and to complete the food diary to check for compliance to the diet. Subjects are asked to bring collected urine to the the Human Nutrition Unit of the Food and Drug Department of the University of Parma.
On the morning of the third day of diet, subjects will be requested to arrive at Parma University in fasting conditions. Prior to receiving the intervention, fasting spot urine and saliva samples will be collected. Then, sugared-decaffeinated-coffee (3 doses of 50 mL each and 5g of sugar) or sugared-water (150 mL of water and 5g of sugar) will be provided according to randomization of the arms, along with a standardized breakfast consisting of a (poly)phenol-free, nutritionally balanced solid meal and water (ad libitum).
After breakfast, subjects will be asked to autonomously collect urine for the next 48h at specified timepoints (0 - 3h; 3 - 6h; 6 - 9h; 9 - 12h; 12 - 24h; 24 - 36h; and 36 - 48h), following the same personalized diet. Lastly, subjects will autonomously collect a fecal sample within 6 to 48h after the intervention.
On the morning of the last day, after the last urine collection, subjects will bring collected urine and fecal samples and the 5-day food diary to the Human Nutrition Unit of the Food and Drug Department of the University of Parma.
After the first arm, subjects will resume their habitual lifestyles for 2 consecutive weeks, subsequently, they will attend another visit, when all the anthropometric evaluations carried out during the first visit will be repeated and another kit with foods and information for the personalized diet will be given. With the study being a cross-over design, the protocol followed will be the same as the one described above (except for saliva sampling, which will only be performed once). Coming the third day of diet, subjects who ingested coffee in the prior arm of the study will ingest water, and vice-versa.
For this study, the sample size was estimated considering the mean concentration of coffee-derived (poly)phenols and their metabolites in urine as the primary outcome and the available literature on similar approaches and studies of the area. The number of 30 volunteers was established considering the accepted parameters for clinical trials (power set at 0.8 and α set at 0.05) possible dropouts (15% drop-out rate), and exclusion of volunteers to maintain the sample power for statistical analysis. Before any comparison is performed, the normality of each variable will be evaluated to choose the most appropriate statistical test. If metabolite data are normally distributed, data will be expressed as mean ± standard deviation and analysed using repeated measures t-test or ANOVA with post-hoc comparisons. If data are not normally distributed, they will be reported as median and Interquartile Range and the Friedman test with post hoc pairwise comparisons will be performed. P-value \< 0.05 will be regarded as statistically significant.
Unsupervised and supervised multivariate analysis will be used to identify and characterize the different urinary metabotypes, following the procedures developed by our research group for targeted metabolomics analysis of phenolic metabolites or when using untargeted metabolomics data. We will be using different clustering approaches to better explore the existing variability. This will serve to establish the number of clusters (i.e., phenolic metabotypes), the number of participants forming each cluster and the similarities among possible metabotypes.
The relationship between patterns of LMWP and their putative determinants (age, sex, ethnicity, lifestyle, anthropometrics, body composition, genotype, and gut microbiome) will be explored using correlation tests and multivariate analyses. P-value \< 0.05 will be regarded as statistically significant. Statistics will be carried out by the specialized staff of the Human Nutrition Unit, under the supervision of the PI, and in collaboration with the University teams in charge of microbial profiling and genotyping.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SCREENING
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coffee
In this arm, volunteers will receive, once, 3 decaffeinated coffees (150 mL total) with sugar as a known source of (poly)phenols.
Coffee
Decaffeinated coffee with 1 pack (5g) of sugar from commercially available brands prepared with commercially available domestic coffee machines.
Control
In this arm, volunteers will receive, once, 150 mL of sugared water as control.
Water
150 mL of hot water with 1 pack (5g) of sugar from commercially available brands prepared with commercially available domestic coffee machines.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coffee
Decaffeinated coffee with 1 pack (5g) of sugar from commercially available brands prepared with commercially available domestic coffee machines.
Water
150 mL of hot water with 1 pack (5g) of sugar from commercially available brands prepared with commercially available domestic coffee machines.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 20-40 years old,
* Body mass index (BMI) between 18-28,
* Regular coffee consumers (at least 1 cup a day).
Exclusion Criteria
* Clinical diagnosis of cardiovascular diseases,
* Clinical diagnosis of renal diseases,
* Clinical diagnosis of digestive diseases,
* Immunodeficiency
* Autoimmune diseases (other than well-compensated hypothyroidism),
* Mental disorders
* Regular use of medication (except birth-control pills and hormone replacement therapies),
* Use of antibiotics in the last month prior to enrollment,
* Food allergies or intolerances,
* Pregnancy
* Lactation
20 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Parma
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pedro M. Mena Parreño
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pedro M Mena Parreño, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Parma
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Parma - Plesso Biotecnologico Integrato
Parma, PR, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
340/2023/SPER/UNIPR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.